VYNE Therapeutics
VYNE
VYNE
32 hedge funds and large institutions have $22.9M invested in VYNE Therapeutics in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 33 → 32 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$913K | |
| 2 | +$675K | |
| 3 | +$534K | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$338K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$265K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$685K | |
| 3 | -$140K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$72.1K |
| 5 |
HF
HRT Financial
New York
|
-$23K |